Medicrea International SA Ret. on assets
What is the Ret. on assets of Medicrea International SA?
The Ret. on assets of Medicrea International SA is -5.89%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on LSE compared to Medicrea International SA
What does Medicrea International SA do?
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Companies with ret. on assets similar to Medicrea International SA
- Kuros Biosciences AG has Ret. on assets of -5.90%
- Ridgeline Minerals has Ret. on assets of -5.90%
- Bombay Rayon Fashions has Ret. on assets of -5.90%
- AstiVita has Ret. on assets of -5.89%
- Urban Logistics REIT plc has Ret. on assets of -5.89%
- Southwest Securities International Securities has Ret. on assets of -5.89%
- Medicrea International SA has Ret. on assets of -5.89%
- CASH Services has Ret. on assets of -5.87%
- LleidaNetworks Serveis Telematics, S.A has Ret. on assets of -5.87%
- SPDR Gold Trust has Ret. on assets of -5.87%
- SPDR Gold Trust has Ret. on assets of -5.87%
- WildBrain has Ret. on assets of -5.86%
- Crossover Acquisitions has Ret. on assets of -5.86%